Fibrinólisis Farmacológica en el Ictus Isquémico Agudo. Experiencia en un Hospital Terciario del Ecuador

Claudio Scherle Matamoros, Dannys Rivero Rodríguez, Daniella Di Capua Sacoto, Elena De Los Ángeles Mullo Almache, María José Santacruz Villalba, Verónica Nuñez Cabezas, Felipe Tohme Sussmann, Nelson Maldonado Samaniego

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

1 Cita (Scopus)

Resumen

Introduction. Pharmacological thrombolysis in ischemic stroke is associated with a better recovery. Objective. Describe the thrombolysis results after using r-Tpa applying an intrahospital stroke code, during one year. Methods. A prospective, longitudinal study was performed in patients with cerebral infarction admitted to the stroke unit, with clinical follow-up up to 3 months after hospital discharge. The variables evaluated were compared in two groups of patients (only one group received the treatment). Results. 107 patients were studied: 16 (14.9%) were thrombolyzed, 29 (27.1%) arrived in the therapeutic window period and 76 (71%) arrived after 4.5 hours. The average age was 68, 8 years and women predominated. The greatest impact of thrombolysis was on the difference in score between the initial assessment and the discharge on the NIHSS scale. At three months of evolution, the percentage of patients with mild disability (Rankin 0-2) was almost equal in the two groups. Mortality increased in patients with more severe disability (Rankin 3-5). Conclusions. Treatment with r-Tpa shows benefits at hospital discharge. Further analysis is required with a greater number of cases.

Título traducido de la contribuciónPharmacological thrombolysis in ischemic stroke. Experience in a tertiary hospital from Ecuador
Idioma originalEspañol
Páginas (desde-hasta)32-38
Número de páginas7
PublicaciónRevista Ecuatoriana de Neurologia
Volumen28
N.º1
EstadoPublicada - 2019

Palabras clave

  • Cerebral infarction
  • Ecuador
  • Fibrinolysis
  • Stroke
  • Thrombolytic therapy

Huella

Profundice en los temas de investigación de 'Fibrinólisis Farmacológica en el Ictus Isquémico Agudo. Experiencia en un Hospital Terciario del Ecuador'. En conjunto forman una huella única.

Citar esto